Ion Beam Applications S.A.

IBA (Ion Beam Applications S.A.) is a global leader in particle accelerator technology, headquartered in Louvain-la-Neuve, Belgium. The company's core mission is to advance proton therapy technology, aiming to make this sophisticated cancer treatment more widely accessible worldwide.

IBA is the primary supplier of equipment and services within the proton therapy sector, recognized as the most advanced form of radiation therapy available today. Additionally, the company provides solutions for industrial sterilization, radiopharmaceuticals, and dosimetry.

As a certified B Corporation (B Corp), IBA adheres to stringent standards of verified social and environmental performance. The company reported a backlog of €1.5 billion as of 2024. In December 2024, an initiative was announced to strengthen its shareholder base, with Management Anchorage acquiring a 21% stake in Sustainable Anchorage, the reference shareholder, to ensure long-term strategic alignment.